Hycor Biomedical
Hycor Biomedical is a US-based in vitro diagnostics manufacturer specializing in allergy and autoimmune testing. Its flagship NOVEOS microbead-based IgE assay platform serves clinical laboratories, hospitals, and doctors' offices worldwide, with FDA and CE-marked products across a 200+ allergen menu.
- Company typePrivate
- Founded1981
- HeadquartersGarden Grove, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Hycor Biomedical does
Hycor Biomedical (HYCOR Biomedical LLC) is a US-based in vitro diagnostics manufacturer headquartered in Garden Grove, California, founded in 1981 and operating with 51-100 employees. The company specializes in allergy and autoimmune diagnostic products for clinical laboratories, hospitals, and doctors' offices worldwide, with its flagship NOVEOS system representing the first major technological innovation in routine allergy diagnostics in approximately 20 years. NOVEOS is a microbead-based IgE antibody assay platform using chemiluminescent detection with a heterogeneous assay design that avoids biotin and cross-reactive carbohydrate determinant (CCD) interference, requires only 4 microliters of sample per test, and runs liquid ready-to-use reagents with automated walk-away capabilities. The company also markets legacy HYTEC and AUTOSTAT product lines.
Hycor monetizes through a combination of NOVEOS instrument sales, recurring specific IgE (sIgE) and component-resolved diagnostic (CRD) reagents across an allergen menu of 200+ assays (CE-marked for Europe), and service agreements for instrument maintenance and customer support. Go-to-market combines direct enterprise sales via a "Book A Demo" channel with regional distributor networks, particularly across Europe where the company maintains localized websites for German, French, and Spanish-speaking markets. Distribution is supported by scientific content marketing including peer-reviewed publications, webinars, white papers, and conference posters.
Hycor received FDA 510(k) clearance for NOVEOS in December 2018 and CE mark for the EU the same year, establishing regulatory footholds in the two largest markets. The company has raised approximately $89.6M across five disclosed funding rounds from 2017 through 2022 and operates as a privately held entity with no public listing. Key scientific partners include Johns Hopkins University School of Medicine (Dr. Robert Hamilton) and European GTM partner Axonlab. The company's competitive positioning emphasizes interference avoidance, miniaturized sample requirements, and laboratory workflow efficiency against established allergy diagnostic platforms such as Thermo Fisher's ImmunoCAP.
Hycor Biomedical firmographics
Firmographics- Name
- Hycor Biomedical
- Legal name
- HYCOR Biomedical LLC
- Website
- https://hycorbiomedical.com
- Company type
- Private
- Founded year
- 1981
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Hycor Biomedical is a US-based in vitro diagnostics manufacturer specializing in allergy and autoimmune testing. Its flagship NOVEOS microbead-based IgE assay platform serves clinical laboratories, hospitals, and doctors' offices worldwide, with FDA and CE-marked products across a 200+ allergen menu.
- Ownership category
- akta.pro rank
Hycor Biomedical industry classification
Industry- Product category
- In Vitro Allergy Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)
- akta.pro secondary industries
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Autoimmune & Allergy Diagnostics (HLAAALAK)
Keywords
Where Hycor Biomedical is headquartered
LocationHeadquarters
- HQ city
- Garden Grove
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Hycor Biomedical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- NOVEOS Allergy Testing System: Sale of the NOVEOS instrument system and associated specific IgE (sIgE) assays for allergy diagnostics in clinical laboratories, hospitals, and doctors' offices.
- Specific IgE Assay Reagents: Sale of specific IgE allergen assays including extract-based and component-resolved diagnostics (CRD) reagents. The company offers over 200 allergens with CE mark for Europe.
- HYTEC and AUTOSTAT Brands: Sale of legacy HYTEC and AUTOSTAT brand products for allergy and autoimmune testing used in clinical laboratories worldwide.
- Service Agreements: Service agreements and technical support for instrument maintenance and customer care.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Hycor Biomedical product offering
Product offeringCore offering
Hycor Biomedical manufactures and sells the NOVEOS in vitro allergy testing system, a microbead-based IgE antibody assay analyzer requiring only 4 µL of sample per test, together with a menu of more than 200 specific IgE allergen assays and component-resolved diagnostics (CRD) reagents. The system uses chemiluminescent detection and a heterogeneous assay design that avoids biotin and CCD interference, and is sold with service agreements to clinical laboratories, hospitals, and doctors' offices worldwide alongside the legacy HYTEC allergy and AUTOSTAT autoimmune product lines.
Product overview
Hycor Biomedical offers a portfolio of in vitro diagnostic products for allergy and autoimmune testing. The primary product is the NOVEOS System, a modern immunoassay analyzer using proprietary microbead-based technology for specific IgE (sIgE) and total IgE testing. The NOVEOS system features a 4 µL sample requirement and proprietary interference avoidance mechanisms. Supporting product lines include HYTEC and AUTOSTAT brands. The company provides an extensive allergen menu with over 200 specific IgE assays and component-resolved diagnostics through the NOVEOS platform.
Differentiator
Problem solved
Functional benefit
Brands
- NOVEOS: Modern allergy testing immunoassay system using microparticle technology with 4μL sample requirement and reduced interference from biotin and CCD structures.
- HYTEC
- AUTOSTAT
Products and services
- NOVEOS Allergy Testing System A modern allergy testing immunoassay analyzer using proprietary microbead-based IgE antibody assay technology with chemiluminescent detection for specific IgE (sIgE) and total IgE testing. Requires only 4 µL sample volume, avoids biotin and CCD interferences through heterogeneous assay design, and runs liquid ready-to-use reagents with automated walk-away capability for clinical laboratories, hospitals, and doctors' offices.
- NOVEOS Specific IgE Allergen Assays Specific IgE allergen test assays for use on the NOVEOS system, covering multiple allergen categories including mites, epidermal and animal proteins, foods, and molds. Over 200 allergens available with CE mark for Europe, offered as both extract-based and component-resolved diagnostics reagents.
- NOVEOS Allergen Component Testing (CRD) Component-resolved diagnostics (CRD) using molecular cloning techniques to create recombinant allergen components, enabling improved molecular-level allergy diagnosis particularly for complex cases such as mold allergy. For use on the NOVEOS platform.
- HYTEC Allergy Testing Products Legacy brand of allergy in vitro diagnostic products used in clinical laboratories, hospitals, and doctors' offices worldwide. Part of Hycor Biomedical's long-standing allergy testing portfolio alongside NOVEOS.
- AUTOSTAT Autoimmune Testing Products Legacy brand of autoimmune in vitro diagnostic test kits used in clinical laboratories worldwide. Part of Hycor Biomedical's diagnostic product portfolio addressing autoimmune disease testing alongside its allergy franchise.
Quantifiable outcome
- NOVEOS and ImmunoCAP have similar performances for diagnosing food allergies
- +1 more outcomes
Companies that use Hycor Biomedical
Customer profileSegments4 records
Ideal customer profiles3 records
Hycor Biomedical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Hycor Biomedical partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- Johns Hopkins University School of MedicinecoreDr. Robert G. Hamilton, Ph.D., D.ABMLI, Professor of Medicine and Pathology at Johns Hopkins University School of Medicine provided expert commentary on NOVEOS technology as a novel diagnostic testing option with unique small sample size requirements for identifying sensitization in patients suspected of having allergic disease.
- AxonlabcoreAxonlab partnered with HYCOR to present webinars on advancements in specific IgE testing, featuring expert speakers including Dr. Robert Hamilton and PD Dr. Skevaki. Webinar focused on evidence supporting NOVEOS as a new standard in allergy diagnostics.
- Healthcare Professional OrganizationsminorCompany provides educational resources and scientific literature for healthcare professionals, including allergy testing information and product insights to support accurate diagnosis and effective patient management.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
Hycor Biomedical competitors and assessment
Company assessmentBroad incumbents
- Roche Diagnostics: Roche's cobas immunoassay platform competes in the clinical lab allergy testing market with broad menu coverage. A diversified incumbent with global reach and deep clinical laboratory relationships overlapping Hycor's customer base.
- Beckman Coulter (Danaher): Beckman Coulter offers the Access and DxI immunoassay platforms that include allergy and autoimmune testing menus. A broad incumbent serving the same clinical laboratory customers that Hycor targets with NOVEOS.
- Bio-Rad Laboratories: Bio-Rad is a diversified life science and clinical diagnostics company with significant presence in immunoassay instruments, quality controls, and autoimmune/allergy testing reagents. It serves similar clinical laboratory customers with broader portfolio depth than Hycor.
- Siemens Healthineers: Siemens Healthineers offers the IMMULITE and Atellica immunoassay platforms that compete for clinical lab allergy and autoimmune testing workloads. A broad incumbent with global commercial reach overlapping Hycor's hospital and reference lab customer base.
- Abbott Diagnostics: Abbott's Alinity and ARCHITECT immunoassay platforms compete in clinical lab allergy and autoimmune testing globally. A diversified incumbent with extensive installed base and broad menu across Hycor's addressable workflows.
Direct peers
- EUROIMMUN (PerkinElmer/Revvity): EUROIMMUN is a leading specialty diagnostics manufacturer for autoimmune and allergy testing using immunoassay and immunofluorescence technologies. Highly comparable to Hycor's portfolio across the autoimmune (AUTOSTAT) line and allergy IgE assays.
- Inova Diagnostics: Inova Diagnostics (a Werfen company) specializes in autoimmune disease diagnostics using immunoassay and immunofluorescence technologies. Directly comparable to Hycor's AUTOSTAT autoimmune product line and overlap in clinical lab end users.
- Thermo Fisher Scientific (ImmunoCAP): Thermo Fisher's ImmunoCAP is the dominant specific IgE (sIgE) allergy diagnostics platform globally. It is Hycor's primary benchmark and direct competitor in routine clinical allergy blood testing, as evidenced by NOVEOS comparison studies published in peer-reviewed journals.
Regional players
- Stallergenes Greer: Stallergenes Greer is a global allergy-focused company (headquartered in Europe) that primarily provides allergen immunotherapy products, but also develops allergy diagnostics. Comparable focus on the allergy domain and clinical end users, with regional (European) concentration overlapping Hycor's EU footprint.
Emerging players
- Bühlmann Laboratories: Bühlmann Laboratories is a Swiss specialty diagnostics company focused on allergy, autoimmune, and inflammatory bowel disease testing using ELISA and immunoassay technologies. Comparable niche specialty IVD player targeting similar clinical lab end users, though smaller scale than Hycor.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Hycor Biomedical social profiles
Digital presenceHycor Biomedical compliance and trust
Trust signalCompliance2 records
Hycor Biomedical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hycor Biomedical leadership team
Management profileNumber of profiles
Profiles3 records
Hycor Biomedical subsidiaries and ownership
Company hierarchySubsidiaries1 record
Hycor Biomedical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hycor Biomedical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hycor Biomedical
What does Hycor Biomedical do?
Hycor Biomedical manufactures and sells the NOVEOS in vitro allergy testing system, a microbead-based IgE antibody assay analyzer requiring only 4 µL of sample per test, together with a menu of more than 200 specific IgE allergen assays and component-resolved diagnostics (CRD) reagents. The system uses chemiluminescent detection and a heterogeneous assay design that avoids biotin and CCD interference, and is sold with service agreements to clinical laboratories, hospitals, and doctors' offices worldwide alongside the legacy HYTEC allergy and AUTOSTAT autoimmune product lines.
Is Hycor Biomedical a public or private company?
Hycor Biomedical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Hycor Biomedical founded?
Hycor Biomedical was founded in 1981. It employs 51 to 100 people.
Where is Hycor Biomedical based?
Hycor Biomedical is headquartered in Garden Grove, United States, in the North America region.
How does Hycor Biomedical make money?
Four revenue lines are on record. NOVEOS Allergy Testing System is the primary driver. The others are specific IgE Assay Reagents, HYTEC and AUTOSTAT Brands and service Agreements.
Who are Hycor Biomedical's main competitors?
Broad incumbents on record are Roche Diagnostics, Beckman Coulter (Danaher), Bio-Rad Laboratories, Siemens Healthineers and Abbott Diagnostics. Direct peers are EUROIMMUN (PerkinElmer/Revvity), Inova Diagnostics and Thermo Fisher Scientific (ImmunoCAP). Stallergenes Greer is listed as a regional player. Bühlmann Laboratories is listed as an emerging player.
Does Hycor Biomedical have an API?
No public API is recorded for Hycor Biomedical.
What industry is Hycor Biomedical in?
Hycor Biomedical's product category is In Vitro Allergy Diagnostics. Its primary akta.pro industry code is HLAHAAAK, Autoimmune, Allergy & Specialized Immunology Diagnostics, with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 325413 and its SIC code is 2835.